Inflammation Manager HA Series

A high-precision nitric oxide (NO) measurement device designed for detecting NO and non-oxygen carbon dioxide in exhaled gas. The eNoglow series includes models LN1000, LN2000, LN3000, and LN4000, with a measurement range of 0-5000ppb and a resolution of 0.01ppb. It is a Class II medical device registered with China's NMPA and designed to meet the high standards required in clinical settings such as pediatrics, cardiology, and intensive care units.

Fractional exhaled nitric oxide (FeNO) measurement system for non-invasive assessment of airway inflammation. Utilized in diagnosis and monitoring of asthma, COPD, and chronic respiratory conditions with high-precision sensing technology.

The NObreath® FeNO device measures fractional exhaled nitric oxide (FeNO) to assess airway inflammation and aid in asthma diagnosis and management. This non-invasive breath test conforms to BTS/NICE/SIGN, ATS, and ERS guidelines and is suitable for both adult and pediatric patients. The device includes ambient NO monitoring capability for environmental assessment.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

Diagnostic system detecting nitric oxide in exhaled breath to evaluate airway inflammation and diagnose primary ciliary dyskinesia. Provides non-invasive assessment of respiratory tract conditions.

A diagnostic device for measuring nitric oxide (NO) levels in exhaled breath, available in models Reslink R100 and Reslink R200. It has a measurement range of 1-3500ppb and is a Class II medical device certified by China's NMPA. The device is used for assisting in the diagnosis and assessment of conditions such as asthma and chronic obstructive pulmonary disease, as well as for monitoring disease progression.

Fenobreath is a diagnostic test device for monitoring respiratory function and airway health. It measures exhaled nitric oxide (FeNO) levels to aid in asthma diagnosis, assessment, and management. The device provides rapid, non-invasive testing suitable for clinical and point-of-care settings.

A breath diagnostic system that detects nitric oxide in exhaled breath to evaluate airway inflammation and diagnose ciliary dyskinesia.

System for detecting nitric oxide and carbon dioxide levels in human breath samples. Supports both oral and nasal breathing modes with measurement range of 1ppb to 3500ppb. Used for non-invasive monitoring of respiratory and circulatory parameters.

Component of the IOS system that measures alveolar nitric oxide (CaNO) as part of comprehensive airway inflammation assessment. Provides specific measurement of lower respiratory tract inflammation in a single integrated testing protocol.